Sheppard Mullin represented Avego Management (Avego), a healthcare-focused investment firm, as lead investor in a $22,000,000 financing round for PBS Biotech, an innovative, single-use bioreactor manufacturer and process development services provider. PBS Biotech received additional financing from existing investor BroadOak Capital Partners. The financing will be used to improve the company's products portfolio, expand its process development services capability, and increase customer support for global cell therapy clients.
The Sheppard Mullin deal team that advised Avego was led by Farha Moiduddin and Shon Glusky. Invaluable assistance was provided by Jonathan Barker, Dmitriy Chelnitsky, Theo Mayer, Zana Operta, Andrea Ramos, Jennifer Redmond, Joey Tongson, Daniel Yannuzzi, Carol Archer, Leo Caseria, Frank Dworak, Keith Gercken, Deena Muzafar, Kaley Rush and Jason Schendel.
Click here to read the press release.